These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 12016797)
1. [Changes of TF and TFPI activities in patients with hypertension or coronary atherosclerotic heart disease]. Xiao Z; Wang W; Han J; He X; Li J Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):251-2, 255. PubMed ID: 12016797 [TBL] [Abstract][Full Text] [Related]
2. [Levels of plasma TF and TFPI activities in patients with acute leukemia]. Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017 [TBL] [Abstract][Full Text] [Related]
3. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162 [TBL] [Abstract][Full Text] [Related]
4. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study. Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291 [TBL] [Abstract][Full Text] [Related]
5. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease. Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809 [TBL] [Abstract][Full Text] [Related]
6. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels. Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632 [TBL] [Abstract][Full Text] [Related]
7. The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease. Opstad TB; Pettersen AA; Bratseth V; Arnesen H; Seljeflot I Pathophysiol Haemost Thromb; 2010; 37(2-4):98-103. PubMed ID: 21555871 [TBL] [Abstract][Full Text] [Related]
8. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis. Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034 [TBL] [Abstract][Full Text] [Related]
9. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques. Migdalski A; Kotschy M; Jawien A Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):41-7. PubMed ID: 15933981 [TBL] [Abstract][Full Text] [Related]
10. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease. Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324 [TBL] [Abstract][Full Text] [Related]
11. [Tissue factor and tissue factor pathway inhibitor during specific bronchial challenge in allergic asthma patients]. Kemona-Chetnik I; Bodzenta-Lukaszyk A; Kucharewicz I; Rogalewska AM Przegl Lek; 2005; 62(2):98-101. PubMed ID: 16095153 [TBL] [Abstract][Full Text] [Related]
12. Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation. Adams M; Breckler L; Stevens P; Thom J; Baker R; Oostryck R Haematologica; 2004 Aug; 89(8):985-90. PubMed ID: 15339683 [TBL] [Abstract][Full Text] [Related]
13. Plasma tissue factor levels and salivary tissue factor activities of periodontitis patients with and without cardiovascular disease. Emekli-Alturfan E; Basar I; Malali E; Elemek E; Oktay S; Ayan F; Emekli N; Noyan U Pathophysiol Haemost Thromb; 2010; 37(2-4):77-81. PubMed ID: 21293108 [TBL] [Abstract][Full Text] [Related]
14. [Observation on tissue factor pathway during the onset of acute cerebral infarction]. Wen ZB; Xiong SL; He XF; He MX; He SL; Xie QZ; Jian ZF; Chen FP; Xiao B; Yang QD Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):529-31. PubMed ID: 12971845 [TBL] [Abstract][Full Text] [Related]
15. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells. Zhao Y; Zhou S; Heng CK Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1645-50. PubMed ID: 17463335 [TBL] [Abstract][Full Text] [Related]
16. Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels. Agledahl I; Brodin E; Svartberg J; Hansen JB Thromb Haemost; 2009 Mar; 101(3):471-7. PubMed ID: 19277407 [TBL] [Abstract][Full Text] [Related]
17. [Tissue factor (TF) and inhibitor (TFPI) concentrations in patients with urinary tract tumors and haematological malignancies]. Radziwon P; Schenk JF; Mazgajska K; Boczkowska-Radziwon B; Galar M; Kłoczko J; Wojtukiewicz MZ Pol Merkur Lekarski; 2002 Oct; 13(76):308-11. PubMed ID: 12557438 [TBL] [Abstract][Full Text] [Related]
18. [Study on platelet-associated tissue factor and its significance]. Huang XL; Chen FP; Du JW; Peng MY; Fu B; Xie QZ; He SL Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):525-8. PubMed ID: 16468328 [TBL] [Abstract][Full Text] [Related]
19. Tissue factor in acute coronary syndromes. Ott I Semin Vasc Med; 2003 May; 3(2):185-92. PubMed ID: 15199481 [TBL] [Abstract][Full Text] [Related]
20. [Dynamic changes of plasma tissue factor and tissue factor pathway inhibitor-1 and their clinical significance in patients with multiple traumas]. Zhou ZQ; Deng Z; Wang WD; Yang F Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2501-3. PubMed ID: 20034913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]